Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market

Introduction. As part of a comparative assessment of drugs quality available on the Russian market a dissolution profile studies and uniformity of dosage units test was conducted for various manufacturers of "Captopril" drugs. Drug release studies in three dissolution media (0.1 M hydrochl...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Yu. Grebenkin, A. V. Ryabova, A. M. Kuramshina, I. V. Kislyakov, E. D. Zhukova
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2023-02-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/1444
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839586653873635328
author D. Yu. Grebenkin
A. V. Ryabova
A. M. Kuramshina
I. V. Kislyakov
E. D. Zhukova
author_facet D. Yu. Grebenkin
A. V. Ryabova
A. M. Kuramshina
I. V. Kislyakov
E. D. Zhukova
author_sort D. Yu. Grebenkin
collection DOAJ
description Introduction. As part of a comparative assessment of drugs quality available on the Russian market a dissolution profile studies and uniformity of dosage units test was conducted for various manufacturers of "Captopril" drugs. Drug release studies in three dissolution media (0.1 M hydrochloric acid, acetate buffer pH 4.5, phosphate buffer pH 6.8) with sampling at 0, 5, 10, 15, 20, 30 min and analysis using UV/Vis spectrophotometer at 212 nm were conducted. Dissolution kinetics was compared based on calculation of the similarity factor f2 and the values of relative standard deviations. Uniformity of dosage units test of scored tablets were evaluated based on HPLC-UV analysis and AV factor calculation.Aim. The purpose of this study was a comparative evaluation of "Captopril" drugs from various manufacturers on the Russian market based on dissolution profile studies and uniformity of dosage units test of scored tablets in order to assess the quality of the tablets.Materials and methods. To prove the dissolution profile studies DT 827/1000 tester (ERWEKA GmbH, Germany) was applied. Each drug in three dissolution media in 12 replicates for each dissolution medium was analyzed. The selected samples were analyzed on a UV 1800 UV spectrophotometer (Shimadzu, Japan) at a of 212 nm. In uniformity of dosage units test of scored tablets each tablet was divided according to the applied mark. Sample preparation was carried out in accordance with a validated method and samples were analyzed by HPLC-UV using Agilent 1260 (Agilent Technologies, США).Results and discussion. Based on the results of dissolution profile studies and calculations of the similarity factors and values of the relative standard deviation it can be concluded that the dissolution kinetics for drug no. 4, drug no. 5, drug no. 6 are not equivalent in comparison with the reference drug. During the uniformity of dosage units test of scored tablets, no deviations were found in accordance with the requirements of the RF Pharmacopoeia OFS.1.4.2.0008.18 "Uniformity of dosing" and the EAEU Pharmacopoeia OFS.2.1.9.14 "Uniformity of Dosed Units".Conclusion. The conducted dissolution profile studies and uniformity of dosage for scored tablets of Captopril drugs show the example of possibility to identify potential problems with drugs quality presented on the Russian market and as a result improve and maintain quality assurance of drugs for the national healthcare system.
format Article
id doaj-art-0c9681febbbb4d65b74d9b2d4b9f5527
institution Matheson Library
issn 2305-2066
2658-5049
language Russian
publishDate 2023-02-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-0c9681febbbb4d65b74d9b2d4b9f55272025-08-03T19:23:58ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492023-02-0112113114110.33380/2305-2066-2023-12-1-131-1411081Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian MarketD. Yu. Grebenkin0A. V. Ryabova1A. M. Kuramshina2I. V. Kislyakov3E. D. Zhukova4LLC "Exacte Labs, Russia"LLC "Exacte Labs, Russia"LLC "Exacte Labs, Russia"LLC "Exacte Labs, Russia"LLC "Exacte Labs, Russia"Introduction. As part of a comparative assessment of drugs quality available on the Russian market a dissolution profile studies and uniformity of dosage units test was conducted for various manufacturers of "Captopril" drugs. Drug release studies in three dissolution media (0.1 M hydrochloric acid, acetate buffer pH 4.5, phosphate buffer pH 6.8) with sampling at 0, 5, 10, 15, 20, 30 min and analysis using UV/Vis spectrophotometer at 212 nm were conducted. Dissolution kinetics was compared based on calculation of the similarity factor f2 and the values of relative standard deviations. Uniformity of dosage units test of scored tablets were evaluated based on HPLC-UV analysis and AV factor calculation.Aim. The purpose of this study was a comparative evaluation of "Captopril" drugs from various manufacturers on the Russian market based on dissolution profile studies and uniformity of dosage units test of scored tablets in order to assess the quality of the tablets.Materials and methods. To prove the dissolution profile studies DT 827/1000 tester (ERWEKA GmbH, Germany) was applied. Each drug in three dissolution media in 12 replicates for each dissolution medium was analyzed. The selected samples were analyzed on a UV 1800 UV spectrophotometer (Shimadzu, Japan) at a of 212 nm. In uniformity of dosage units test of scored tablets each tablet was divided according to the applied mark. Sample preparation was carried out in accordance with a validated method and samples were analyzed by HPLC-UV using Agilent 1260 (Agilent Technologies, США).Results and discussion. Based on the results of dissolution profile studies and calculations of the similarity factors and values of the relative standard deviation it can be concluded that the dissolution kinetics for drug no. 4, drug no. 5, drug no. 6 are not equivalent in comparison with the reference drug. During the uniformity of dosage units test of scored tablets, no deviations were found in accordance with the requirements of the RF Pharmacopoeia OFS.1.4.2.0008.18 "Uniformity of dosing" and the EAEU Pharmacopoeia OFS.2.1.9.14 "Uniformity of Dosed Units".Conclusion. The conducted dissolution profile studies and uniformity of dosage for scored tablets of Captopril drugs show the example of possibility to identify potential problems with drugs quality presented on the Russian market and as a result improve and maintain quality assurance of drugs for the national healthcare system.https://www.pharmjournal.ru/jour/article/view/1444"captopril"dissolution profile studiesuniformity of dosagetablets
spellingShingle D. Yu. Grebenkin
A. V. Ryabova
A. M. Kuramshina
I. V. Kislyakov
E. D. Zhukova
Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market
Разработка и регистрация лекарственных средств
"captopril"
dissolution profile studies
uniformity of dosage
tablets
title Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market
title_full Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market
title_fullStr Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market
title_full_unstemmed Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market
title_short Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market
title_sort dissolution profile study and uniformity of dosage units test for various manufacturers of captopril drugs from the russian market
topic "captopril"
dissolution profile studies
uniformity of dosage
tablets
url https://www.pharmjournal.ru/jour/article/view/1444
work_keys_str_mv AT dyugrebenkin dissolutionprofilestudyanduniformityofdosageunitstestforvariousmanufacturersofcaptoprildrugsfromtherussianmarket
AT avryabova dissolutionprofilestudyanduniformityofdosageunitstestforvariousmanufacturersofcaptoprildrugsfromtherussianmarket
AT amkuramshina dissolutionprofilestudyanduniformityofdosageunitstestforvariousmanufacturersofcaptoprildrugsfromtherussianmarket
AT ivkislyakov dissolutionprofilestudyanduniformityofdosageunitstestforvariousmanufacturersofcaptoprildrugsfromtherussianmarket
AT edzhukova dissolutionprofilestudyanduniformityofdosageunitstestforvariousmanufacturersofcaptoprildrugsfromtherussianmarket